Device Trial Radar · NCT06585579
The Effect of Mucogyne® Ovule on Wound Healing (ORIGYNE)
Last checked: Nov 20, 2026Latest source record: Sep 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
144
Planned (sponsor's estimate)
Start
Oct 2024
Primary completion
Aug 2025
Study completion Nov 2025
Sponsor
- Lead sponsor
- BiocodexNot on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 5, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This clinical investigation is a post-market clinical follow-up performed to confirm the performance and safety of the Mucogyne® ovule medical device in promoting the process of wound healing, when used in accordance with its approved labelling, in the context of local cervicovaginal surgery.
Conditions
- Cervicovaginitis
Interventions
Mucogyne OvuleDevice
In Mucogyne group, patient will receive 2 boxes of Mucogyne® ovule. 24 hours after intervention, the patient will apply Mucogyne® ovule, 1 ovule per day for 10 days, to be repeated as needed (for practices' homogenisation, after the 10th day, it is recommended to apply one ovule every second day, until EOS visit)
Primary outcomes
What the sponsor says the trial is designed to measure.
- To confirm the performance of Mucogyne® ovule in wound healing promotionTime frame: Day 0 to day 21(+10)
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
CHU Amiens-Picardie
Amiens, France
CHU Besançon
Besançon, France
Hôpital Nord Franche-Comté
Trévenans, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.